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Abstract
Background: Accurate classification into genotypes is critical in understanding evolution of divergent viruses. Here
we report a new approach, MuLDAS, which classifies a query sequence based on the statistical genotype models
learned from the known sequences. Thus, MuLDAS utilizes full spectra of well characterized sequences as
references, typically of an order of hundreds, in order to estimate the significance of each genotype assignment.
Results: MuLDAS starts by aligning the query sequence to the reference multiple sequence alignment and
calculating the subsequent distance matrix among the sequences. They are then mapped to a principal coordinate
space by multidimensional scaling, and the coordinates of the reference sequences are used as features in
developing linear discriminant models that partition the space by genotype. The genotype of the query is then
given as the maximum a posteriori estimate. MuLDAS tests the model confidence by leave-one-out cross-validation
and also provides some heuristics for the detection of ‘outlier’ sequences that fall far outside or in-between
genotype clusters. We have tested our method by classifying HIV-1 and HCV nucleotide sequences downloaded
from NCBI GenBank, achieving the overall concordance rates of 99.3% and 96.6%, respectively, with the benchmark
test dataset retrieved from the respective databases of Los Alamos National Laboratory.
Conclusions: The highly accurate genotype assignment coupled with several measures for evaluating the results
makes MuLDAS useful in analyzing the sequences of rapidly evolving viruses such as HIV-1 and HCV. A web-based
genotype prediction server is available at http://www.muldas.org/MuLDAS/.
Background
We are observing rapid growth in the number of viral
sequences in the public databases [1]: for example, HIV-
1 and HCV sequence entries in NCBI GenBank have
doubled almost every three years. These viruses also
show great genotypic diversities and thus have been
classified into groups, so-called genotypes and subtypes
[2,3]. Consequently classifying these virus strains into
genotypes or subtypes based on their sequence similari-
ties has become one of the most basic steps in under-
standing their evolution, epidemiology and developing
antiviral therapies or vaccines. The conventional classifi-
cation methods include the following: (1) the nearest
neighbour methods that look for the best match of the
query to the representatives of each genotype, so-called
references (e.g., [4]); (2) the phylogenetic methods that
look for the monophyletic group to which the query
branches (e.g., [5]). Since the genotypes have been
defined originally as separately clustered groups, these
intuitively sound methods have been widely used and
quite successful for many cases.
However, with increasing numbers of sequences, we
are observing outliers that cannot be clearly classified
(e.g., [6]) or for which these methods do not agree.
A recent report that compared these different automatic
methods with HIV-1 sequences showed less than 50%
agreement among them except for subtypes B and C
[7]. One of the reasons for the disagreement was attrib-
uted to the increasing divergence and complexity caused
by recombination. It was also noted that closely related
subtypes (B and D) or the subtypes sharing common
origin (A and CRF01_AE) showed poor concordance
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bottom of this problem is that the number of reference
sequences per subtype was too small; these methods
have used two to four reference sequences. Having been
carefully chosen by experts among the high-quality
whole-genome sequences, they are to cover the diversity
of each subtype as much as possible [2]. However with
intrinsically small numbers of references per subtype,
they cannot address the confidence of subtype predic-
tions; a low E-value of a pairwise alignment or a high
bootstrap value of a phylogenetic tree indicates the relia-
bility of the unit operation, but does not necessarily
guarantee a confident classification.
Recognition of this issue of lacking a statistical confi-
dence measure, brought about the introduction of the
probabilistic methods based on either position-specific
scoring matrix [8] or jumping Hidden Markov Models
(jpHMM) [9-11] built from multiple sequence alignment
(MSA) of each genotype. By using full spectra of
reference sequences, jpHMM was effective in detecting
recombination breakpoints. Recently, new classification
methods based on nucleotide composition strings have
been introduced [12]. It is unique in that it bypasses the
multiple sequence alignment and still achieves high
accuracy. However, it uses only 42 reference sequences
and has been tested with 1,156 sequences. Considering
the explosive increase in the numbers of these viral
sequences, the test cases of these conventional methods
were rather small, an order of ten thousands at most. It
would be desirable to measure the performance of a
new classification method over all the sequences pub-
licly available.
It is critical to evaluate how well each genotype popu-
lation is clustered, before attempting to classify a query
sequence. Consider a case where the reference
sequences are mostly well segregated by genotype except
for two or more genotypes that overlap at least partially
(see Figure 1 for an illustration); those methods that rely
Figure 1 A schematic diagram illustrating the concept of classification of a viral sequence. The filled spheres represent known sequences
that have been clustered into four groups, a through d, the boundaries of which are depicted by black circles. Suppose the dark spheres in
each cluster represent the respective reference sequences and the red asterisk denotes a query sequence. Since the query is located at the
interface of b and d clusters, its genotype (or subtype) is elusive. On the other hand, a nearest neighbour method may assign it to the nearest
reference sequence, which happens to be d in this example. If the classification method does not take into account the clustering patterns of
the known sequences and relies on the distances to the nearest reference sequences, its result may not be robust to the choice of references.
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may assign an apparent genotype with a high score. Due
to varying mutation rate along the sequence range, the
phylogenetic power of each gene segment may also vary
[13]. This is particularly critical for relatively short par-
tial sequences. In other words, even the well character-
ized references that are otherwise distinctively clustered
may not be resolved if only part of the sequence region
is considered in the classification. The nearest neighbour
methods do not evaluate this validity of the background
classification models, since they concern the alignments
of only query-to-reference, not reference-to-reference.
REGA, one of the tree-based methods, concerns whether
the query is inside or outside the cluster formed by a
group of references [5]. The branching index has been
proposed to quantify this and has been useful in detect-
ing outlier sequences [14,15]. A statistical method,
jpHMM, reports the posterior probabilities of the sub-
types at each query sequence position; based on these,
some heuristics is given to assess the uncertainty in
detecting recombination region [11].
Here we present a new method, MuLDAS, which
develops the background classification models based on
the distances among the reference sequences, re-evalu-
ates their validity for each query, and reports the statis-
tical significance of genotype assignment in terms of
posterior probabilities. As such, it is suited for the cases
where many reference sequences are available. MuLDAS
achieves such goals by combining principal coordinate
analysis (PCoA) [16] with linear discriminant analysis
(LDA), both of which are well established statistical
tools with popular usages in biological sciences. PCoA,
also known as classical multidimensional scaling (MDS),
maps the sequences to a high-dimensional principal
coordinate space, while trying to preserve the distance
relationships among them as much as possible. It has
been widely applied to the discovery of global trends in
a sequence set, complementing tree-based methods in
phylogenetic analysis [17,18]. Since genotypes have been
defined as distinct monophyletic groups in a phyloge-
netic tree, each genotype should form a well separated
cluster in a MDS space if an appropriately high dimen-
sion is chosen. In such cases, we can find a set of hyper-
planes that separate these clusters and classify a query
relative to the hyperplanes. For this purpose, MuLDAS
applies LDA [19], a straightforward and powerful classi-
fication method, to the MDS coordinates and assigns a
query to the genotype that shows the highest posterior
probability of membership. This probability can be use-
ful in detecting any ambiguous cases, for which careful
examination is required. MuLDAS tests the LDA models
through the leave-one-out cross-validation (LOOCV),
which can be used to assess the model validity by exam-
ining the misclassification rate. As the sequences are
represented by coordinates, a simple measure can be
also developed for detecting genotype outliers. We have
tested the algorithm with virtually all the HIV-1 and
HCV sequences available from NCBI GenBank and the
results are presented.
Methods
Overall Process
A flowchart of the algorithm is shown in Figure 2. MuL-
DAS starts the process by creating a multiple sequence
alignment (MSA) of the query with the reference
sequences. MuLDAS requires a large number of refer-
ences, which should be of high quality and with care-
fully assigned genotypes. Los Alamos National
Laboratory (LANL) databases distribute such MSAs of
HIV-1 http://www.hiv.lanl.gov/ and HCV http://hcv.lanl.
gov/ sequences. LANL also provides the genotype infor-
mation on each sequence in the MSA. A total of 3,591
nucleotide sequences were included in the 2007 release
of HIV-1 MSAs (Supplementary Table 1 in Additional
File 1), while a total of 3,093 nucleotide sequences were
in HCV MSAs (Supplementary Table 2 in Additional
File 1). It should be noted that for some genotypes,
more than 100 sequences were found in the MSA, while
there were rare genotypes for which only a few refer-
ence sequences were included [20,21]. This imbalance in
sample sizes is a serious problem to MuLDAS but we
propose rather a heuristic solution that is based on the
global variance (vide infra). For a fair comparison with
other methods, we decided to honour the MSA of refer-
ence sequences already available from the public data-
bases by aligning the query to this reference MSA,
rather than creating MSA by ourselves. This has the
advantage of saving the execution time, which is crucial
for a web server application (see the section ‘Web server
development’). The suit of programs, hmmbuild,
hmmcalibrate,a n dhmmalign http://hmmer.janelia.org/
are used for this step. After removing indels in the MSA
using a PERL script, the pairwise distance matrix among
these sequences is calculated using distmat of EMBOSS
package http://emboss.sourceforge.net/ with the Jukes-
Cantor correction.
The next step is so-called principal coordinate analysis
(PCoA), which turns the distance matrix to a matrix
whose components are equivalent to the inner products
of the sought coordinates. Through singular value
decomposition of the resulting matrix, a set of eigenvec-
t o r sa n da s s o c i a t e de i g e n v a l u e sa r eo b t a i n e du pt ot h e
specified lower dimensions. The multidimensional coor-
dinates of the sequences whose pairwise Euclidean dis-
tances approximate the original distances, are then
recovered from a simple matrix operation involving the
eigenvectors and eigenvalues (for details see [16]). Each
eigenvalue is the amount of variance captured along the
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Page 3 of 18Figure 2 A flowchart of the algorithm for a given gene segment. MuLDAS starts by aligning the query with the pre-maid MSA of reference
sequences, which includes CRFs in HIV-1. Through this, the gene segments to which the query maps are identified and the whole process is
repeated over these gene segments. After distance matrix is obtained, MDS and LDA are performed to classify the query. In HIV-1, only the
major groups are used in this step. The genotype gives rise to the best posterior probability is reported as the major genotype. If nested analysis
is not required as for HCV, the process stops here. Otherwise as for HIV-1, an additional process called nested analysis (shown in red) is
performed. For the major analysis, the genotypes that give rise to P > 0.01 and their associated CRFs are identified, and the subset of the
distance matrix corresponding to these genotypes is excised from the original matrix saved in the major analysis. After MDS and LDA, the best
genotype is reported as the nested genotype. Once both nested and major genotypes are determined, a decision process outlined at the bottom
proceeds from left to right and suggests the final outcome (see “a proposed process for subtype decision” section for details).
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called as the principal coordinate (PC). For convenience
the eigenvalues are sorted in descending order and
dimensionality reduction is achieved by taking the top
few components. If the within-group variation is negligi-
ble, the number of top PCs or the MDS dimensionality,
k, should be at most N-1, where N is the number of
reference groups. However, depending on the sequence
region considered, a genotype might show a complex
clustering pattern, splitting into more than one cluster.
Consequently we took an empirical approach that sur-
veyed the cross-validation error of the reference
sequences for k ranging from 1 to 50 (see the next sub-
section). This step is implemented with cmdscale in the
R statistical system http://www.r-project.org/. See Figure
3 for an exemplary plot of the MDS result.
Figure 3 An exemplary MDS plot of HIV-1 sequences along the first (V1), second (V2), and third (V3) principal coordinate axes.T h e
reference sequences were shown as small circles colour-coded according to their subtypes. For clarity the subtypes F-K were not labelled. The
query was located in the middle of subtype B (’+’). The image was created with GGobi http://www.ggobi.org/.
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nant models that best classify the references according
to their genotypes and assign the genotype membership
to the query according to the models. Here one can
envisage applying various classification methods such as
K-Nearest Neighbour (K-NN), Support Vector Machine
(SVM), and linear classifiers, among others. If the refer-
ences are well clustered according to their genotype
membership, then the simplest methods such as linear
discriminant analysis (LDA) or quadratic discriminant
analysis (QDA) should work. Both of them work by fit-
ting a Gaussian distribution function to each group cen-
tre, while the difference between them is whether global
(LDA) or group (QDA) covariance is used. Since it can
be expected that the within-group divergences may dif-
fer from one group to another, QDA may be better sui-
t e d .H o w e v e r ,t h es a m p l es i z ei m b a l a n c ei s s u e
mentioned above prevents applying QDA as it becomes
unstable with a small number of references for some
genotypes. On the other hand, LDA applies the global
covariance commonly to all the genotypes and thus may
be more robust to this issue. Although it is not as rigor-
ous as QDA, this heuristic approach works reasonably
well as long as the group divergences are not too differ-
ent from one to another. Once the linear discriminants
are calculated based on the reference sequences, the
posterior probability of belonging to a particular group
is given as a function of so-called Mahalanobis distance
from the query to the group centre [19]. To the query,
the maximum a posteriori (MAP) estimate, that is, the
genotype having the maximum probability is then
assigned. The posterior probability is scaled by the prior
that is proportional to the number of references for
each genotype. This step is implemented with lda of
MASS package in the R statistical system http://www.r-
project.org/.
Cross-Validation of the Prediction Models
The validity of the linear discriminant models are
assessed by LOOCV of the genotype membership of the
reference sequences. For each one of the references, its
genotype is predicted by the models generated from the
rest of the references. The misclassification error rate,
which is the ratio of the number of misclassified refer-
ences to the total number of references participated in
the validation, is a sensitive measure of the background
classification power. Many viral sequences in the public
databases are not of the whole genome but cover only a
few genes or a part of a gene, and thus their phyloge-
netic signal may be variable [13]. Consequently we re-
evaluate the classification power of each prediction
using LOOCV. If the reference sequences are not well
resolved in the MDS space for a given query, it would
be evident in LOOCV, resulting in a high misclassifica-
tion rate.
Outlier Detection
Even if the references are well separated by genotype
with a low LOOCV error rate, it might be possible that
the query sequence itself is abnormal: it could be a com-
posite of two or more genotypes, located in the middle
of several genotypes (a recombinant case); it might be
close to only one genotype cluster (having a posterior
P value close to 1 for that subtype) but far outside the
cluster periphery (a divergent case). In the field of multi-
variate analysis, it is customary to detect outliers by cal-
culating Mahalanobis distance from the sample centre
and by comparing it with a chi-square distribution [22].
As the Mahalanobis distances have already been incor-
porated into the calculation of the LDA posterior prob-
ability, we propose a measure somewhat distinct,
namely, outlierness, O, which is the Euclidian distance
from the query to the cluster centre relative to the max-
imum divergence of the references belonging to that
subtype along that direction:
O
XQ XC
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XR XC XQ XC
=
−
∈
−⋅− ⎡ ⎣ ⎤ ⎦
2
max ( )( )
(1)
where XQ, XR,a n dXC are the MDS vectors of the
query, one of the references, and the centre of the
reference group, S, respectively. The group, S,c o n t a i n s
all the reference sequences belonging to the genotype
to which the query has been classified. If O is smaller
than 1.0, the query is well inside the cluster, and out-
side otherwise. We can develop a simple heuristic filter
based on this: for example, a threshold can be set at
2.0 in order to tolerate some divergence. A similar
measure, the branching index, has been devised for
tree-based methods to detect outlier sequences by
measuring the relative distance from the node of the
query to the most recent common ancestor (MRCA)
of the genotype cluster [14,15]. See Supplementary
Note 1 in Additional File 2 for the comparison of ‘out-
lierness’ with the branching index. If a truly new geno-
type is emerging, MuLDAS may classify such
sequences into one of the genotypes (a nominal geno-
type). Their posterior probabilities may be very high
but the ‘outlierness’ values from the nominal group
would be also very high. We simulated such a situation
by leaving all the reference sequences of a given geno-
type out and classifying them based on the reference
sequences from the other groups only. Indeed O values
were consistently large. See Supplementary Note 2 in
Additional File 2 for details.
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There are a number of methods for characterizing
recombinant viral strains [23]. Similar to the tree-based
bootscanning method [24], MuLDAS can be run along
the sequence in sliding windows to locate the recombi-
nation spot. It is applicable to long sequences only and
takes too much time to be served practically through
web for a tool such as MuLDAS that relies on large
sample sizes unless a cluster farm having several hun-
dred CPUs is employed. Rather than attempting to
detect de novo recombinant forms by performing slid-
ing-window runs, we classify the query to the well
defined common recombinant forms by the following
approaches: (a) predicting genotypes gene by gene for a
query that encompass more than one gene; (b) re-itera-
tion of the analysis in a ‘nested’ fashion that includes
recombinant reference sequences. HIV-1 and HCV con-
tains an order of 10 genes and thus gene by gene analy-
s i so faw h o l eg e n o m es e q u e n c em a yt a k e1 0t i m e s
longer than a single gene analysis. If different genotypes
are assigned with high confidences to different gene seg-
ments of a query, it may hint a recombinant case. For
some recombinants, the breakpoint may occur in the
middle of a gene. In such cases, it is likely that the pos-
terior probability of classification is not dominated by
j u s to n eg e n o t y p eb u tt h es e c o n do rs ow o u l dh a v ea
non-negligible P value. We re-iterate the prediction pro-
cess in a ‘nested’ fashion by focusing on the genotypes
having the P value greater than 0.01 and the associated
common recombinant genotypes. For example, the
references in the ‘nested’ round of HIV-1 classification
would include CRF02_AG group if the P value of either
A or G group were greater than 0.01. We have imple-
mented this procedure for classifying HIV-1 sequences,
for which some common recombinant groups known as
circulating recombinant forms (CRFs) have been
described [2]. Although recombinant forms have been
known for HCV, no formal definitions of common
forms are available at the moment [3].
One may argue in favour of an alternative approach
where the reference CRF sequences are included into
the MSA of the major group sequences and do the clas-
sification in a single operation. In multidimensional scal-
ing, both divergent and close sequences are mapped to
the same space, the latter are not well resolved. As CRF
sequences are often clustered near their ostensible non-
recombinant forms, they are not resolved if they are
included in the MSA with all the other major group
sequences.
Web Server Development
Apache web servers that accept a nucleotide sequence as
a query and predicts the genotype for each gene seg-
ment of the query has been developed, one for each of
HIV-1 and HCV. These are freely accessible at http://
www.muldas.org/MuLDAS/. Each CGI program written
in PERL wraps the component programs that have been
downloaded from the respective distribution web sites
of HMMER, EMBOSS, and R. As the calculation of dis-
tance matrix consumes much of the run time, we split
the task into several, typically four, computational
nodes, each of which calculates parts of the rows in par-
allel, and the results are integrated by the master node.
A typical subtype prediction of a 1000-bp HIV-1 nucleo-
tide sequence takes around 20 seconds on an Intel Xeon
CPU Linux box. The web servers report the MAP geno-
type of the query as well as the posterior P for each
genotype, the leave-one-out cross-validation result of
the prediction models, and the outlier detection result
(see Supplementary Figure 1 in Additional File 3 for
screenshots). The 3 D plot of the query and the refer-
ences in the top three PCs are given in PNG format and
an XML file describing all the PCs of the query and the
references can be downloaded for a subsequent dynamic
interactive visualization with GGobi http://www.ggobi.
org/ (Figure 3). This is particularly useful for visually
examining the quality of clustering and for confirming
the outlier detection result that may lead to the discern-
ment of potential new types or recombinants. If the
number of reference sequences for a particular geno-
type, the classification by MuLDAS would be subopti-
mal. In such cases, interactive visualization of the
clustering pattern using GGobi m a ya l s ob eu s e f u l .F o r
HIV-1, the ‘nested’ analysis as described above is re-iter-
ated and the result is reported as well.
Results and Discussion
The MuLDAS algorithm was tested with the sequence
datasets of HIV-1 and HCV downloaded from NCBI
GenBank. The genotype information of nucleotide
sequences was retrieved from the LANL website for
158,578 HIV-1 (including 6,203 CRFs) and 40,378 HCV
sequences (non-recombinants only) that have not been
used as the reference sequences. For some of the
sequences, the genotypes/subtypes were given by the
original submitters and otherwise they were assigned by
LANL. We considered these datasets as ‘gold standards’
for benchmarking the performance of MuLDAS.
Genotype/Subtype nomenclatures of the test datasets
HIV-1 sequences are grouped into M (main), N (non-
main), U (unclassified) and O (outgroup) groups [2].
Most of the sequences available belong to M group. As
N and O groups are quite distant from M group, the
subtypes of M group cannot be well resolved in the
MDS plot that includes these remote groups. Conse-
quently, we focused on classifying M group sequences
i n t os u b t y p e s ,A - D ,F - H ,J ,a n dK .A m o n gMg r o u p
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subtypes, A1 and A2, and F1 and F2, respectively [2].
However, some new sequences were still being reported
at the subtype level in the LANL database. This was the
case even to the sequences included in MSA produced
by LANL. Resolving sub-subtypes for relatively short
sequences using MuLDAS would require a ‘nested’ ana-
lysis using the relevant subtype sequences only. Due to
these reasons, we did not attempt to distinguish sub-
subtypes and classified them at the subtype level. Differ-
ent subtypes of the M group sequences may recombine
to form a new strain [1]. If these strains were found in
more than three epidemiologically independent patients,
they are called circulating recombinant forms (CRFs).
Among the CRFs, CRF01_AE was formed by recombina-
tion of A and now extinct E strains, and constitutes a
large family that is distinct from subtype A [2]. We have
called the M group and CRF01_AE subtypes as the
‘major’ subtypes and the MuLDAS run against them as
the ‘major’ analysis. Supplementary Table 3(a) in Addi-
tional File 1 lists the breakdown of the statistics by sub-
types and gene segments of all the test nucleotide
sequences that have been classified to the ‘major’ groups
by LANL. The distribution was far from uniform, repre-
senting study biases: sequences belonged to subtypes H,
J, and K were rare; especially for auxiliary proteins such
as vif and vpr, non-B strains were too rare to evaluate
the classification accuracy.
HCV sequences are now classified as genotypes 1
through 6 and their subtypes are suffixed by a lower
case alphabet: for example, 1a, 2k, 6h and so on [3].
The multiple sequence alignments downloaded from the
LANL website included only a few sequences per sub-
type that were to be used as references by MuLDAS,
making it difficult to apply MuLDAS at the subtype
level. Since these genotypes were roughly equidistant
from each other [3], MuLDAS was applied at the geno-
type level, and all the subtypes from a genotype were
lumped together into a group. See Supplementary
Tables 4(a) in Additional File 1 for the breakdown of
HCV nucleotide sequences, respectively.
Determination of MDS dimensionality and assessment of
model validity
The discriminant models are built solely from the refer-
ence sequences and thus their validity is largely irrele-
vant to the query sequence itself. On the hand, what
gene and which portion of the genome the query corre-
sponds to are critical to the discriminatory power as the
phylogenetic signal varies along the genome [13,25]. We
address this issue by using the LOOCV error rates,
which are measured by counting the reference
sequences that are misclassified from the class predic-
tion based on the rest of the references. First we looked
for the optimum MDS dimensionality, k, by surveying
the error rates for each whole gene segment. We, then,
surveyed the error rates in sliding windows of each gene
segment with that k. It is expected that the classification
power of our discriminant models will increase by
representing the sequences in higher and higher k.W e
surveyed the misclassification error rate from LOOCV
runs by varying k from 1 through 50. As shown in Fig-
ure 4, the error rates dropped quickly, reaching a pla-
teau for k > = 10. Except for HIV-1 5’-tat, excellent
performance (error rate < 5%) was observed with k >=
10. For HIV-1, short gene segments generally showed
poorer performance. While there is no noticeable
increase in computational overhead in incrementing k
from 10 to 50, higher k might fall into overfitting. We
therefore use k = 10 throughout the analysis, while the
prediction web server allows changing this parameter.
We, then, measured the variation in discriminatory
power along the genome or for each gene segment by
measuring LOOCV error rates in sliding windows (100
bp windows in 10 bp step). Representative plots for
HIV-1 env and HCV e2 are shown in Figure 5 (see Sup-
plementary Figures 2 and 3 in Additional File 3 for full
listings). In general, the error rates were fairly low along
the gene segment, although some distinct peaks were
observed. The dominant peak seen in HIV-1 env and
HCV e2 corresponds to V3 loop and HVR1, respectively.
If the query sequence is composed of primarily of these
regions, the high sequence variability is likely to cause
suboptimal performance of MuLDAS or any other geno-
typing tools. In tree-based methods, this will create
branches composed of mixed genotypes. In such cases,
the assessment of the clustering quality would be ambig-
uous. On the other hand, MuLDAS provides several
means for quality assurance: a LOOCV error rate, pos-
terior probabilities of membership, and an ability to
inspect distribution of the sequences in multidimen-
sional space. Even for the cases where the LOOCV error
rate is around 10%, the classification can be still valid if
the query is found in a region of the multidimensional
space where the contaminations by the other genotypes
are negligible. Our web-based genotype prediction server
masks by default these hyper-variable regions in the
query sequence.
Performance tests
The issue raised above would not be a serious problem
as long as the major portion of the query contains good
phylogenetic signals. This can be best addressed by run-
ning the MuLDAS classification for the entire real world
s e q u e n c e st h a ta r en o ti n c l u d e di nt h er e f e r e n c ep a n e l
and tabulating the LOOCV error rates. The shortest
query sequence included in our initial benchmark test
was 50 bp long. It would be informative to evaluate the
Kim et al. BMC Bioinformatics 2010, 11:434
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ably the best way to assess this issue is to survey the
leave-one-out cross-validation (LOOCV) error rate by
sequence length. Since it is purely based on reference
sequences only, it would be the optimal performance of
MuLDAS. The relevant scatter plots were created for
both HIV-1 and HCV nucleotide sequences (see Supple-
m e n t a r yF i g u r e4i nA d d i t i o n a lF i l e3 ) .T h eL O O C V
error rate rises sharply below 100 bp, reaching to about
0.20. Accordingly in the subsequent analysis we used
only those sequences longer than 100 bp. Table 1 shows
the summary of such runs with all the non-recombinant
nucleotide sequences greater than 100 bp. The LOOCV
error rates were very low: mean and median being less
than 1%. For both HCV and HIV-1 nucleotide
sequences, more than 99% of the cases had LOOCV
error rates of about 4% or less.
Having demonstrated that the MuLDAS linear models
were well validated, we then surveyed the posterior
probability of classification: more than 99% of the cases
showed the maximum a posteriori probability values of
0.90 or higher, meaning unambiguous calls for most
cases (Table 1). The overall concordance rates of the
MuLDAS predictions with those retrieved from LANL
were 98.9% and 96.7%, respectively for HIV-1 and HCV
sequences (Table 1). See the next section for the plausi-
ble explanation for the apparently low concordance for
HCV.
The concordance rates for each gene and genotype are
l i s t e di nT a b l e s2a n d3f o rH I V - 1a n dH C Vn u c l e o t i d e
sequences, respectively (see Supplementary Tables 3 and
4 in Additional File 1 for details). If only a few reference
sequences are available for any gene-genotype combina-
tion, the statistical model of genotype classification for
that category would be unreliable: for example, only two
to three references were available from each of subtypes
H, J, and K (Supplementary Table 1 in Additional File
1). The test sequences in these categories were also
extremely rare (Supplementary Tables 3(a) and 4(a) in
Additional File 1). Unless more sequences are discov-
ered from these subtypes, their classification using MuL-
DAS remains to be a challenge.
Outlier filtering
Having proposed the outlierness value, O (Eq. 1), as an
indicator of how well the query clustered with the corre-
sponding references, we examined its distribution: the
density plots of O showed a sharp peak centred around
1.0 for the concordant predictions (bar), while a long
tail up to 10.0 were observed for discordant cases (line)
(Figure 6(a, b)). If one treats the discordant cases as
false positives, we can survey the false discovery rate
(FDR) over the entire range of O cutoff (Figure 6(c, d)).
It appears that the cutoff at O =2 . 0w o u l de l i m i n a t e
much of the misclassifications with a minimal sacrifice
of concordant predictions. While noticeable improve-
ment was observed with HIV-1 sequences, no improve-
ment was observed with HCV sequences (Table 1). A
closer examination of the confusion table between HCV
genotypes before and after the filtering showed some
Figure 4 Surveys of LOOCV error rates by MDS dimensionality, k, for each gene segment. The LOOCV error rates of predicting genotypes
(or subtypes) of references sequences were measured by varying the MDS dimensionality, k, from 1 through 50 for each gene segment of (a)
HIV-1 and (b) HCV nucleotide sequences. Some gene segments showing distinctively higher error rates are labelled. Regardless of sequence
types, the error rates reached plateaus after k = 10, which was used in the subsequent analyses.
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Page 9 of 18specific patterns of discordance (Supplementary Table 4
(e, f) in Additional File 1). It appears they were due to
systematic errors in LANL HCV genotype information
of these sequences. For example, most of these cases
were originated from a few studies that had submitted
several hundreds to thousands of sequences. See
Additional File 2 Supplementary Note 3 for details.
After removing all the sequences from those submis-
sions of suspicious genotype information, the overall
concordance rate for HCV were 99.45 and 99.50, respec-
tively before and after applying the cutoff at O =2 . 0
(Supplementary Table 5 in Additional File 1). Since the
Figure 5 Representative sliding window plots of LOOCV error rates along gene segments. The LOOCV error rates were plotted in sliding
windows of 100 bp in 10 bp step along the gene segment of (a) HIV-1 env and (b) HCV e2 nucleotide sequences. The MDS dimensionality was
set at k = 10 for both cases. Full listings are given in Supplementary Figures 2 and 3 in Additional File 3.
Kim et al. BMC Bioinformatics 2010, 11:434
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Page 10 of 18concordance was already extremely high, the outlierness
filtering showed only marginal improvement. Neverthe-
less the revised histogram and FDR plots of showed that
the cutoff at O = 2.0 would eliminate some of the mis-
classifications (Supplementary Figure 5 in Additional
File 3).
Assessment of the HIV-1 nested analysis results
Many HIV-1 sequences have been described as circulat-
ing recombinant forms (CRFs) by LANL. For a total of
9,000 nucleotide gene segments of 8,612 such sequence
entries, subtypes were assigned by MuLDAS by the
‘nested’ analysis (see Methods). After the ‘major’ analysis
of each gene segment, the subtypes having posterior
probability greater than 0.01 were identified and the
corresponding reference sequences were collected into a
pool. The CRF references originated from these subtypes
were also added to the pool. The MuLDAS classification
model was, then, built based on the pool of references,
and was applied to the query sequence. Note that the
reference pool was re-collected for each query. A total
of 4,994 nucleotide gene segments (derived from 4,949
sequence entries) passed the filtering step (O ≤ 2.0) and
had unambiguous calls (posterior probability ≥ 0.99),
with an overall accuracy of 94.67% (Supplementary
Table 6 in Additional File 1). It should be noted that
the number of reference sequences per gene segment or
subtype is not high for CRFs presently and consequently
the accuracy reported here should be interpreted care-
fully. The relatively high accuracy seen with pol
sequences (Supplementary Tables 6 Additional File 1)
Table 1 Summary statistics of the benchmarking results
1
Virus HIV-1
2 HCV
# of test sequences 153,669 66,488
LOOCV error rate
mean 0.0100 0.0063
median 0.0068 0.0034
90% percentile 0.0286 0.0155
99% percentile 0.0395 0.0412
MAP
3 (% of sequences higher than the cutoff)
P > = 0.99 97.5 99.6
P > = 0.90 99.1 99.8
P > = 0.50 100.0 100.0
LANL concordance (% of sequences higher than the cutoff)
All 98.9 96.7
O < = 2.0 99.3 96.6
1Data as of Jan. 20, 2009.
2Major analysis (M-group and CRF01) only.
3Maximum a posteriori
Table 2 The test results with HIV-1 sequences
§
Category All Outlierness <
2.0
No. of reference
sequences
Total %
acc.*
Total %
acc.*
(a) by gene segment
Gag 14,915 97.85 14,570 98.65 1,142
pol 64,607 98.67 61,704 99.20 735
vif 1,330 99.62 1,324 100.00 945
vpr 1,713 99.71 1,702 99.71 810
tat 1,987 99.35 1,976 99.44 659
env 63,519 99.17 62,652 99.52 1,175
nef 5,598 99.59 5,572 99.82 1,559
(b) by subtype
A 11,907 95.44 11,317 97.74 259
B 112,997 99.53 111,396 99.64 1,750
C 12,785 99.1 12,586 99.52 908
D 3,743 95.99 3,526 98.24 158
F 1,321 96.14 939 97.12 37
G 2,379 94.33 1,800 95.89 65
H 214 71.03 47 51.06 11
J 124 54.84 15 0 3
K 39 69.23 11 54.55 3
01_AE 8,160 98.80 7,863 98.93 152
Total 153,669 98.86 149,500 99.32 3,346
*% accuracy given as 100 × Matched/Total, where Matched is the number
cases concordant between MuLDAS and LANL
§Major analysis (M-group and CRF01) only.
Table 3 The test results with HCV nucleotide sequences
Class All Outlierness < 2.0 No. of
reference
sequences
Total % acc.* Total % acc.
*
(a) by gene segment
arfp 4,333 99.7 4,167 99.78 289
core 4,453 99.73 4,412 99.77 463
e1 19,353 95.19 19,167 95.15 456
e2 16,025 93.32 15,462 93.27 194
p7 2,156 100 2,120 100 195
ns2 813 100 785 100 166
ns3 3,254 99.97 3,125 99.97 154
ns4a 950 99.58 796 99.75 253
ns4b 921 99.67 787 99.62 148
ns5a 5,870 99.98 5,794 99.98 298
ns5b 5,115 98.14 4,384 98.02 148
okamoto 3,245 97.13 3,240 97.13 2,203
(b) by genotype
1 49,574 99.15 49,462 99.19 1,709
2 3,544 98.87 3,452 98.99 354
3 6,043 99.7 5,810 99.76 473
4 4,026 66.57 2,875 53.25 346
5 1,182 66.75 641 40.72 72
6 2,119 99.76 1,999 99.9 139
Total 66,488 96.66 64,239 96.61 3,093
*% accuracy given as 100 × Matched/Total, where Matched is the number
cases concordant between MuLDAS and LANL
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the targets of antiviral therapies and recent resistance
screenings to help guide treatment regimens frequently
sequence these genes [26].
Even with this success, there were still many
sequences that failed to pass filtering steps. As a classifi-
cation tool, MuLDAS has been developed to assign a
subtype among a set of known subtypes, and thus not
designed to detect a new subtype or recombination
pattern. However, MuLDAS may hint some important
clues for the analysis of these outlier sequences in terms
of outlierness value and a set of posterior probabilities
as well as the complex subtype pattern along the
sequence. See Supplementary Note 4 in Additional File
2 for the summary of the test runs of MuLDAS with
artificial HIV-1 sequences interwoven with two sub-
types. The MuLDAS runs displayed complex subtype
patterns that were generally congruent with the subtype
Figure 6 The density distributions of the outlierness value, O, and the corresponding false discovery rates from the benchmark
results for HIV-1 and HCV nucleotide sequences. For all the HIV-1 (a) and HCV (b) sequences used in the benchmark tests (Table 1), the O
values were surveyed and plotted as the histograms that were separately normalized for the cases concordant with (bar) and discordant to (line)
LANL genotypes/subtypes. After filtering out the cases having O > cutoff, the discordant ones were counted as false positives. The false positive
rates and the proportion of the sequences retained (coverage) were plotted against the O cutoff for HIV-1 (c) and HCV (d) sequences. The
suggested cutoff is shown by a dashed line. The revised plots after removing the HCV sequences of suspicious genotypes are available in
Supplementary Figure 5 in Additional File 3.
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Page 12 of 18composition. For the cases where either the recombina-
tion spot or subtype composition of the query was sub-
stantially different from the common CRFs, its
performance were suboptimal. This implies that sliding-
window analysis by MuLDAS along the sequence is
necessary. We plan to develop MuLDAS further to
implement such a feature, exploiting cluster farms with
several hundred CPUs.
A proposed process for subtype decision
It is evident from the previous sections that one has to
accept the prediction results if and only if the reported
parameters such as posterior probability (P) and outlier-
ness (O) are reasonable. A working proposal for highly
confident genotype assignment may be P better than
0.99 and O less than 2.0. A straightforward application
of such criteria to 100,654 HCV nucleotide gene seg-
ment sequences achieved a false positive rate around
2.6%, leaving about 13.9% as undecided (data not
shown).
The subtype decision for a HIV-1 sequence is not as
straightforward as the genotyping a HCV sequence, as
the former has to deal with the issue of recombinant
forms. We showed that MuLDAS achieved high classifi-
cation accuracies with HIV-1 sequence sets that had
been pre-segregated as non-recombinants or CRFs. In
real situations, we do not know prior to the analysis
whether the query is recombinant or not. For HIV-1
sequences, MuLDAS runs a ‘major’ analysis and subse-
quently a ‘nested’ one (see Methods). An automated
decision process is, then, needed in order to summarize
those statistics in an orderly manner. For example, if the
results from the ‘major’ and ‘nested’ analyses are differ-
ent, the user may be confused. Here the objective is to
maximize the accuracy without sacrificing the prediction
coverage too much. Based on the filtering criteria men-
t i o n e da b o v ew ep r o p o s et h ef o l l o w i n gs t r a t e g y :( i )
accept the result from ‘nested’ analysis only if its cluster-
ing is tight (O ≤ 2.0) and the posterior probability is
greater than or equal to 0.99; (ii) otherwise, accept the
result only if the ‘major’ and ‘nested’ analyses agree with
each other and one of the outlierness values is less than
or equal to 2.0; (iii) or, accept the result from ‘major’
analysis if its outlierness value is less than or equal to
1.0 and the P value is greater than or equal to 0.99. We
applied this strategy to 162,669 HIV-1 nucleotide
sequences (gene segments), for which the subtype infor-
mation were available from LANL (Table 4). A total of
130,721 sequences passed the first step with 98.9% accu-
racy, while the second step (ii) applied to the 31,948
leftovers from the step (i) yielded 22,599 sequences with
94.8% accuracy. The steps (i)-(iii) in this heuristic deci-
sion scheme resulted in 98.1% overall prediction accu-
racy for 94.9% of the total sequences, leaving out 8,274
sequences without subtype assignment (5.1%). By treat-
ing the inaccurate ones as false discovery, we can survey
the false discovery rate (FDR) over the entire range of O
value cutoff for each decision step. See Additional File 3
Supplementary Figure 6 for the plots of FDR overlaid
with coverage. For the first two steps, O cutoff at 2.0
would lower FDR without sacrificing the coverage too
much. On the other hand, the last step showed much
higher FDR over the entire range. Therefore the cutoff
at 1.0, the nominal minimum would be the only choice
in this case.
While an alternative strategy may maximize the pre-
diction coverage at the loss of the accuracy, our
approach minimizes misclassification and leaves the
‘twilight zone’ to the users’ discretion. The latter
included some extreme cases such as those in-between
multiple subtypes (P < 0.6) or far outside the nearest
cluster (O > 10). The lists constitute about 0.7% of the
total HIV-1 nucleotide sequences (Table 4).
Comparison with other methods
We have validated the performance of MuLDAS in gen-
otyping HCV and subtyping HIV-1 sequences against
the benchmark test dataset downloaded from LANL
databases. As MuLDAS shows excellent performance, it
would be informative to compare with other automatic
genotyping (or subtyping) methods. Most published
methods report concordance rates with LANL similar to
those of MuLDAS, even though one of the tests showed
quite discordant results among those methods [7]. How-
ever, their test cases were quite limited, not as full scale
as those of MuLDAS. It should also be emphasized that
all those methods are based on well established core
algorithms in the fields of sequence alignment or phylo-
genetics. As such, appropriate implementations of those
methods should work well for the classification of the
query, as long as it is well clustered with only one of the
genotypes (or subtypes). Therefore it would be more
informative to understand the difference of these meth-
ods in dealing with a problematic query sequence that is
either divergent or recombinant. As there are no such
test panels publicly available, we have devised our own
panels: one panel of genome sequences (length > 9000
bp) for each of HCV and HIV-1. We downloaded 1,218
and 1,131 such genome sequences from GenBank,
respectively for HCV and HIV-1. From LANL, the geno-
types were retrieved for 1,116 and 1,086 of them,
respectively. MuLDAS ran in the gene-by-gene mode. If
all the gene segments of a genome sequence are ‘confi-
dently’ genotyped by MuLDAS (O <2 . 0a n dP > 0.99)
and agree with LANL, we count it as a concordant case,
otherwise discordant.
For HCV, 1,098 out of 1,116 were concordant, leaving
18 cases as discordant (98.4% accuracy). Since we did
Kim et al. BMC Bioinformatics 2010, 11:434
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ence panels for HCV, all these concordant cases corre-
sponded to ‘pure’, non-recombinant forms. On the other
hand, nine out of 18 discordant cases were designated as
recombinant forms by LANL. The gene-by-gene predic-
tions by MuLDAS for these nine sequences were con-
gruent with their recombination patterns. For example,
LANL genotype was “1a/2a” for the sequence entry
AX057088, while MuLDAS predicted ‘1’ and ‘2’ for six
and five segments, respectively. We labelled such cases
as “Recombination inferable”. Including these ‘partial
success’ cases, the success rate goes up to 99.2% (Table
5). Among the remaining nine cases, EU643835 was
designated as a pure genotype ‘6’ by LANL, while MuL-
DAS displayed ‘2/6’ recombination pattern. NCBI Geno-
typing Tool and REGA also indicated a similar
recombination pattern. The next eight cases were
described as non-recombinant forms of genotype 4 by
LANL. There was no consensus among the three geno-
typing methods: many segments were not genotyped
‘confidently’ by MuLDAS; NCBI Tool reported recombi-
nant forms; REGA reported some as pure forms as
LANL. The last one, EF108306, belonged to genotype 7,
which has been defined recently and has not been repre-
sented in the reference sets, yet. The full listing of the
genotype results of these genome sequences is available
in Additional File 4.
For HIV-1, based on the strict criteria mentioned
above, 938 out of 1,086 were concordant with LANL,
leaving 148 cases as discordant (86.3% accuracy). Since
we classify a HIV-1 sequence into M-groups or CRFs
(01~16). Any sequences that do not belong to these
groups are bound to be discordant in this analysis.
Indeed all 148 but seven discordant cases were of com-
plex recombinant ones. The genotype compositions
predicted by MuLDAS for 103 such cases were con-
gruent with their recombination patterns designated by
LANL. For example, LANL genotype for a sequence
entry EU220698 was ‘AC’, a non-CRF recombination
of ‘A’ and ‘C’. Among nine segments, six were of ‘C’
Table 4 Accuracy and coverage of each subtype decision step for HIV-1 nucleotide gene segments
Sequence set* Description No. of sequences Accuracy (%) Coverage (%)
(1) Subtypes given by LANL 162,669 100
(2) [Nested analysis] Outlierness < 2.0 & Pval > 0.99 among (1) 130,721 80.4
Correctly classified among (2) 129,302 98.91
(3) (1)-(2) 31,948 19.6
(4) Outlierness < 2.0 & Subtype(major) = subtype(nested) among (3) 22,599 14.1
Correctly classified among (4) 21,429 94.82
(5) (3)-(4) 9,349 5.7
(6) [Major analysis] Outlierness < 1.0 & Pval > 0.99 among (5) 1,075 0.7
Correctly classified among (6) 781 72.65
(7) (5)-(6) 8,274 5.1
(8) Subtype assigned (2)+(4)+(6) 154,395 94.9
Correctly classified among (8) 151,512 98.13
(9) (1)-(8) 8,274 5.1
Pval < 0.6 among (9) 292 0.2
Outlierness > 10.0 among (9) 756 0.5
*The sequence sets (2), (4), and (6) correspond to the decision steps (i), (ii), and (iii) in the main text of the “A proposed process for subtype decision” section of
Results and Discussion, respectively
Table 5 Concordance between LANL and MuLDAS in genotypes for the genome sequences longer than 9,000 bp
Sequence set HCV HIV-1
(1) Genome sequences downloaded 1,218 1,131
(2) LANL genotypes known in (1) 1,116 1,086
(3) All confidently genotyped gene segments concordant with LANL genotypes 1,098 938
(4) Some confidently genotyped segments discordant to LANL genotypes 18 148
(5) Accuracy [(3)/(2)]% 98.4 86.3
(6) Recombination pattern ‘inferable’ from MuLDAS results among (4) 9 103
(7) Including ‘partial’ successes [(3)+(6)] cases 1,107 1,041
% 99.2 95.9
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Page 14 of 18and three were of ‘A’ by MuLDAS. Including such
‘partial success’ cases, the success rate goes up to
95.9% (Table 5).
We validated the results for 148 discordant HIV-1
cases with independent runs of both NCBI Genotyping
Tool [4] and REGA [5]. NCBI Genotyping Tool offers
an option to choose one from various reference sets.
Since some of the genome sequences used in this test
are included in more recent reference sets, NCBI Geno-
typing Tool would immediately recognize them with
perfect matches. For fair comparisons, we used so-called
“2005 pure and CRFs” as the reference set in the test
run. Since NCBI Genotyping Tool does not summarize
the sliding window result into a single genotype, we
devise our own scheme as follows: for each window the
best scoring genotype is reported; among them infre-
quent ones (<10%) were trimmed. When multiple geno-
types are finally reported for a genome sequence, the
genotype composition is compared with that of LANL.
If they are congruent, we label them ‘inferable’ (73
cases). This scheme was successfully validated with the
938 sequences for which MuLDAS showed concordance
with LANL (Sequence set (3) for HIV-1 in Table 5). On
the other hand REGA summarizes the sliding window
result and report a single genotype. However among
148 sequences, REGA failed to report summarized geno-
types for 107 sequences due to poor bootscanning sup-
port values (we label them “Failed QC”). Thus we
focused on the comparison with NCBI Tool, which
showed 97 and 102 cases (including ‘inferable’)t h a t
were concordant with LANL and MuLDAS, respectively.
There were 79 cases for which all three agreed on. The
results are summarized in Supplementary Table 7 in
Additional File 1, while the full listings of the test results
are found in Additional File 5.
Figure 7 A boxplot of the outlierness values for HIV-1 hypermutated sequences. A boxplot of the outlierness value, O, was drawn for 561
non-functional and 1,519 functional hypermutated sequences reported by three studies that specifically labelled whether each sequence was
‘nonfunctional’ or not [27-29].
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from their ancestors and are often with loss of function in
the component genes. It would be interesting to see how
MuLDAS behaves with such sequences. There were 14
reports of HIV-1 hypermutations whose sequences had
been deposited with the public archives [27-40]. Among
2,308 such sequences, 2,279 were identified from our
benchmark results. Since the sequences with non-func-
tional gene components are likely more divergent than the
intact sequences, we would compare the degree of diver-
gence between the two groups that have originated from
the same studies. Among those 14 reports, three specifi-
cally labelled whether the sequence was non-functional or
not [27-29]. We measured the outlierness, O, parameter
for 561 non-functional and 1,519 functional sequences. As
shown in Figure 7, the former had distinctively higher O
values than the latter. This demonstrates that MuLDAS
may be useful in pre-screening hypermutation. Here we
show an example analysis of a hypermutated sequence
with other tools. Janini et al. [27] described a 297 bp HIV-
1 pol gene coding a non-functional protease due to hyper-
mutation (GenBank accession AY036374.1 and GI:
15192372). The original GenBank record classified it to
subtype A. Although NCBI Genotyping Tool also classi-
fied it as distinct subtype A, there was no obvious indica-
tion of hypermutation. REGA HIV Subtyping Tool
assigned it to subtype A with rather high bootstrap (74%),
although the topological shape of the phylogenetic tree
was unusual. MuLDAS also classified it to subtype A with
high confidence (P = 1.0) but more than 10-fold divergent
than the known subtype A references (Ogroup = 10.56).
Compared to the maximum radius encompassed by all
735 reference sequences, it was almost four-fold divergent
(Oall = 3.99).
Conclusions
Here we have demonstrated that MuLDAS is a novel
approach useful for classifying viral sequences based on
a large sample population of reference sequences. As it
reports several confidence measures, it is a particularly
powerful tool for detecting unusual, problematic
sequences that often slip through unnoticed. Explosive
growth in number coupled with complex divergence of
viral sequences, demands classification tools such as
MuLDAS. It has been a while since the previous meth-
ods were developed and their performances have not
been comprehensively re-evaluated with the sequences
emerged since then. MuLDAS achieved remarkable
accuracy in the tests that included all HIV-1 or all HCV
sequences currently available. As at the core of MuL-
DAS is MDS of distance matrix followed by LDA, it is
conceivable that in place of LDA other classification
algorithms such as K-NN or SVM are applied. However,
they may not be appropriate as they focus on either a
few nearest neighbours (K-NN) or solely on the decision
boundary without taking into consideration of the popu-
lation distribution (SVM). In addition, K-NN may also
suffer from the issue of sample size imbalance. MuLDAS
algorithm is straightforward enough to be applied to the
classification of either nucleotide or peptide sequences.
It can be even extended to classify individual subjects
into population groups based on a distance matrix of
polymorphic markers such as SNP. To sum it up, the
approach taken by MuLDAS has far reaching implica-
tions for sequence classifications.
Note added in proof
The pre-computed genotype/subtype information is
accessible through LinkOut service from NCBI.
Additional material
Additional file 1: Supplementary Tables. Table 1. Number of HIV-1
reference nucleotide sequences per gene segment for each subtype.
Table 2. Number of HCV reference nucleotide sequences per gene
segment for each genotype. Table 3. Summary statistics of the
benchmark test for HIV-1 M group and CRF01_AE nucleotide sequences.
Table 4. Summary statistics of the benchmark test for HCV nucleotide
sequences. Table 5. Re-analysis of the benchmark test for HCV nucleotide
sequences after removing batches of 3,642 sequences that had been
submitted by three studies of suspicious genotype information in LANL
database (see Additional File 2 Supplementary Note 3 for details). Table
6. Benchmark results of HIV-1 CRF nucleotide sequences from ‘nested’
analysis. Table 7. Comparison with other methods for 148 cases that
were discordant between MuLDAS and LANL for HIV-1 genome
sequences longer than 9,000 bp (Sequence set (3) in Table 5)
Additional file 2: Supplementary Notes. Additional analyses and
descriptions provided here include: Note 1. Comparison of ‘outlierness’
with the branching index in tree-based methods. Note 2. Simulation of
new genotype detection by leaving out entire reference sequences of a
given genotype and classifying them based on the other reference
groups. Note 3. Re-analysis of discordant cases of HCV nucleotide
sequences. Note 4. Test results with artificial synthetic HIV-1 nucleotide
sequences.
Additional file 3: Supplementary Figures. Figure 1. Screenshots of
MuLDAS web server for subtyping HIV-1 sequences. Figure 2. LOOCV
error rates in sliding windows for HIV-1 nucleotide sequences. Figure 3.
LOOCV error rates in sliding windows for HCV nucleotide sequences.
Figure 4. The scatter plots of LOOCV error rate by sequence length for
(a) HIV-1 and (b) HCV nucleotide sequences. Figure 5. The density
distributions of the outlierness value, O, and the corresponding false
discovery rates from the benchmark results for HIV-1 and HCV nucleotide
sequences after removing the HCV sequences of suspicious genotypes.
Figure 6. The plots of false discovery rates at each step of the proposed
process for HIV-1 subtype decision.
Additional file 4: Comparison with other methods for HCV genome
sequences. The following spreadsheets are available: ■ Hcv.summary:
summary page to navigate to other sheets. ■ Discordant: the sequences
discordant between LANL and MuLDAS. ■ noDiscordant: the sequences
concordant between LANL and MuLDAS.
Additional file 5: Comparison with other methods for HIV-1
genome sequences. The following spreadsheets are available: ■ Hiv1.
summary: summary page to navigate to other sheets. ■ Discordant: the
sequences discordant between LANL and MuLDAS. ■ noDiscordant: the
sequences concordant between LANL and MuLDAS. ■ pivot noDiscord:
confusion tables between methods for those sequences in the
noDiscord sheet. ■ pivot Discord: confusion tables between methods for
those sequences in the Discord sheet.
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